GLYC Financial Statements From 2010 to 2026
| GLYCDelisted Stock | USD 0.16 0.01 5.88% |
Check GLYC Old financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GLYC Old's main balance sheet or income statement drivers, such as , as well as many indicators such as . GLYC financial statements analysis is a perfect complement when working with GLYC Old Valuation or Volatility modules.
GLYC |
GLYC Old Company Current Valuation Analysis
GLYC Old's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current GLYC Old Current Valuation | 1 B |
Most of GLYC Old's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GLYC Old is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, GLYC Old has a Current Valuation of 1 B. This is 93.02% lower than that of the Biotechnology sector and 78.42% lower than that of the Health Care industry. The current valuation for all United States stocks is 93.97% higher than that of the company.
GLYC Old Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining GLYC Old's current stock value. Our valuation model uses many indicators to compare GLYC Old value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across GLYC Old competition to find correlations between indicators driving GLYC Old's intrinsic value. More Info.GLYC Old is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the GLYC Old's earnings, one of the primary drivers of an investment's value.About GLYC Old Financial Statements
GLYC Old stakeholders use historical fundamental indicators, such as GLYC Old's revenue or net income, to determine how well the company is positioned to perform in the future. Although GLYC Old investors may analyze each financial statement separately, they are all interrelated. For example, changes in GLYC Old's assets and liabilities are reflected in the revenues and expenses on GLYC Old's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in GLYC Old. Please read more on our technical analysis and fundamental analysis pages.
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. GlycoMimetics, Inc. was incorporated in 2003 and is headquartered in Rockville, Maryland. Glycomimetics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 52 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Consideration for investing in GLYC Stock
If you are still planning to invest in GLYC Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the GLYC Old's history and understand the potential risks before investing.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |